Home/Filings/4/A/0001209191-15-009274
4/A//SEC Filing

Horizon Pharma plc 4/A

Accession 0001209191-15-009274

CIK 0001492426operating

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 12:43 PM ET

Size

7.6 KB

Accession

0001209191-15-009274

Insider Transaction Report

Form 4/AAmended
Period: 2014-01-02
SMITH TODD N
SVP, Marketing & Alliance Mgmt
Transactions
  • Exercise/Conversion

    Common Stock

    2014-01-02+13,75054,711 total
  • Exercise/Conversion

    Restricted Stock Units

    2014-01-0213,75041,250 total
    Common Stock (55,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
  • [F2]On January 2, 2013, the reporting person was granted 55,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Issuer

Horizon Pharma plc

CIK 0001492426

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001492426

Filing Metadata

Form type
4/A
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 12:43 PM ET
Size
7.6 KB